Scholarly Works per year
Scholarly Works per year
Fingerprint
Dive into the research topics where Karen Taraszka Hastings is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation
Borden, E. S., Buetow, K. H., Wilson, M. A. & Hastings, K. T., Mar 3 2022, In: Frontiers in Oncology. 12, 836821.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Corrigendum to “Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest” (Translational Oncology (2022) 15(1), (S1936523321002503), (10.1016/j.tranon.2021.101259))
Adams, A. C., Macy, A. M., Kang, P., Castro-Ochoa, K. F., Wijeratne, E. M. K., Xu, Y. M., Liu, M. X., Charos, A., Bosenberg, M. W., Gunatilaka, A. A. L., Sertil, A. R. & Hastings, K. T., Jul 2022, In: Translational Oncology. 21, 101446.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
Adams, A. C., Borden, E. S., Macy, A. M., Thomson, N., Cui, H., Gimbel, M. I., Wilson, M. A., Buetow, K. H., Roe, D. J., Dicaudo, D. J., Homsi, J. & Hastings, K. T., May 1 2022, In: Cancers. 14, 9, 2200.Research output: Contribution to journal › Article › peer-review
Open Access -
NeoScore Integrates Characteristics of the Neoantigen:MHC Class I Interaction and Expression to Accurately Prioritize Immunogenic Neoantigens
Borden, E. S., Ghafoor, S., Buetow, K. H., LaFleur, B. J., Wilson, M. A. & Hastings, K. T., Apr 1 2022, In: Journal of Immunology. 208, 7, p. 1813-1827 15 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Physachenolide C induces complete regression of established murine melanoma tumors via apoptosis and cell cycle arrest
Adams, A. C., Macy, A. M., Kang, P., Castro-Ochoa, K. F., Wijeratne, E. M. K., Xu, Y. M., Liu, M. X., Charos, A., Bosenberg, M. W., Gunatilaka, A. A. L., Sertil, A. R. & Hastings, K. T., Jan 2022, In: Translational Oncology. 15, 1, 101259.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations
-
MHC Class II Antigen Processing and Immune Recognition of Melanoma
Project: Research project
-
GILT and regulation of Treg development in cutaneous autoimmunity
Project: Research project
-
GILT and regulation of Treg development in cutaneous autoimmunity
9/10/13 → 8/31/16
Project: Research project
-
MHC Class II Antigen Processing and Immune Recognition of Melanoma
9/1/07 → 8/31/13
Project: Research project